Interstitial myofibroblasts: Predictors of progression in membranous nephropathy

Journal of Clinical Pathology

Volumn 50, Issue 2, 1997, Pages 123-127

  Roberts, I S D ^a   Burrows, C ^b   Shanks, J H ^a   Venning, M ^c   McWilliam, L J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Fibrosis; Membranous nephropathy; Myofibroblasts

Indexed keywords

ACTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MYOFIBROBLAST; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031050172     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.2.123     Document Type: Article

References (29)

1. Mallick NP, Short CD, Manos J. Clinical membranous nephropathy. Nephron 1983;34:209-19.
2. Ramzy MH, Cameron JS, Turner DR, Neild GH, Ogg CS, Hicks J. The long term outcome of idiopathic membranous nephropathy. Clin Nephrol 1981;16:13-19.
3. Donadio JV, Torres VE, Velosa JA, Wagoner RD, Holley KE, Okamura M, et al. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 1988;33:708-15.
4. Wehrmann M, Bohle A, Bogenschutz O, Eiselle R, Freislederer A, Ohlschlegel C, et al. Long term prognosis of chronic idiopathic membranous glomerulonephritis. Clin Nephrol 1989;31:67-76.
5. Honkanen E. Survival in idiopathic membranous glomerulonephritis. Clin Nephrol 1986;25:122-8.
6. Davison AM, Cameron JS, Kerr DNS, Ogg CS, Wilkinson RW. The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 1984;22:61-7.
7. Murphy BF, Fairley KF, Kincaid-Smith PS. Idiopathic membranous glomerulonephritis: long term follow up in 139 cases. Clin Nephrol 1988;30:175-81.
8. Ong ACM, Fine LG. Loss of glomerular function and tubulointerstitial fibrosis: cause or effect? Kidney Int 1994;45: 345-51.
9. Fine LG, Ong ACM, Norman JT. Mechanisms of tubulointerstitial injury in progressive renal diseases. Eur J Clin Invest 1993;23:259-65.
10. Kuncio GS, Neilson EG, Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int 1991;39:550-6.
11. Alexopoulos E, Seron D, Hartley RB, Nolasco F, Cameron JS. Immune mechanisms in idiopathic membranous nephropathy: the role of interstitial infiltrates. Am J Kidney Dis 1989;13:404-12.
12. Gabbiani G. The biology of the myofibroblast. Kidney Int 1992;41:530-2.
13. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE. The activated mesangial cell: an activated myofibroblast? J Am Soc Nephrol 1992;2:190-7.
14. Alpers CE, Hudkins KL, Floege J, Johnson RJ. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubuloimerstitial and crescentic injury. J Am Soc Nephrol 1994;5:201-10.
15. Skalli O, Schurch W, Seemayer T, Lagace R, Montandon D, Pittet B, Gabbiani G. Myofibroblasts from diverse pathological settings are heterogenous in their content of actin isoforms and intermediate filament proteins. Lab Invest 1989;60:275-285.
16. Sappino AP, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990;63: 144-61.
17. Zhang G, Moorhead PJ, El Nahas AM. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995;3:308-18.
18. Goumenos DS, Brown CB, Shortland J, El Nahas AM. Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant 1994;9:1418-25.
19. Hewitson TD, Becker GJ. Intersitial myonbroblasts in IgA glomerulonephritis. Am J Nephrol 1995;15:111-17.
20. Bohle A, Mackensen-Haen S, Gise H. Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. Am J Nephrol 1987;7:421-33.
21. Bohle A, Muller GA, Wehrmann M, Mackensen-Haen, Xiao J-C. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies and chronic interstitial nephritides. Kidney Int 1996;49:S2-9.
22. Austin HA, Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histological data. Kidney Int 1994;45:544-50.
23. Rodemann HP, Muller GA. Characterisation of human renal fibroblasts: II. In vitro growth, differentiation and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am J Kidney Dis 1991;17:684-6.
24. Eddy AA. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994;5:1273-87.
25. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989;135:719-33.
26. Floege J, Grone H-J. Progression of renal failure: what is the role of cytokines? Nephrol Dial Transplant 1995;10:1575-86.
27. Ong ACM, Fine LG. Tubular derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression. Am J Kidney Dis 1994;23:205-9.
28. Lonnemann G, Shapiro L, Engler-Blum G, Muller GA, Koch KM, Dinarello CA. Cytokines in human renal fibrosis. I. Interleukin-1 is a paracrine growth factor for culture fibrosis-derived kidney fibroblasts. Kidney Int 1995;47: 837-44.
29. Strutz F, Neilson EG. The role of lymphocytes in the progression of interstitial disease. Kidney Int 1994;45: S106-10.